Promising results of studies into consume of solanezumab expected to be announced at Alzheimer’s conference in Washington
Researchers are set to unveil a drug that could befriend to slow down Alzheimer’s disease.
Promising results of studies into the consume of solanezumab are expected to be announced on Wednesday.[br]Continue reading...
Source: theguardian.com